Investing Acceleration of RAD204 Phase 1 dose escalation trial by admin May 12, 2025 May 12, 2025 Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com previous post Triumph Gold Discovers a New Silver and Gold Vein Showing at the Freegold Mountain Project, Yukon next post House GOP unveils Medicaid work requirements in Trump’s ‘big, beautiful bill’ You may also like JZR Gold Announces Full Exercise of Warrants for... October 31, 2025 QEM Appoints Robert Cooper as Director, following Leadership... July 2, 2025 Syntheia Signs Maiden Enterprise Deal with Van-Fort Ontario February 21, 2025 Top 5 Canadian Biotech Stocks in 2025 April 23, 2025 American Rare Earths Forges a New Path to... August 14, 2024 Mawson Finland: Gold, Cobalt Exploration in Lapland Region,... November 1, 2024 Cardiol Therapeutics Enrolls First Patient in Pivotal Phase... April 16, 2025 Radiopharm Theranostics CEO Shares Company Milestones as NASDAQ... November 18, 2024 Galan Lithium Limited (ASX: GLN) – Trading Halt August 5, 2024 Spearmint Acquires the Sisson North Tungsten Project February 13, 2025